APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-animal Type Hard Capsules

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Non-animal Type Hard Capsules Market Analysis and Forecast 2026-2032

22 December 2025204 pages

Choose your research edition.

Industry ResearchNon-animal Type Hard Capsules Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-animal Type Hard Capsules Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Non-animal Type Hard Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-animal Type Hard Capsules Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-animal Type Hard Capsules Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Non-animal Type Hard Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Non-animal Type Hard Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Non-animal Type Hard Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Non-animal Type Hard Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Non-animal Type Hard Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Non-animal Type Hard Capsules include Lonza, Hunan Er-Kang Pharmaceutical Co., Ltd, Sunil Healthcare, Roxlor, Qualicaps (Mitsubishi Chemical), Procaps S.A, Pharco, Patheon (Banner Pharmacaps) and Medicaps, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Non-animal Type Hard Capsules, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Non-animal Type Hard Capsules, also provides the sales of main regions and countries. Of the upcoming market potential for Non-animal Type Hard Capsules, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non-animal Type Hard Capsules sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Non-animal Type Hard Capsules market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Non-animal Type Hard Capsules sales, projected growth trends, production technology, application and end-user industry.

Non-animal Type Hard Capsules Segment by Company

Lonza

Hunan Er-Kang Pharmaceutical Co., Ltd

Sunil Healthcare

Roxlor

Qualicaps (Mitsubishi Chemical)

Procaps S.A

Pharco

Patheon (Banner Pharmacaps)

Medicaps

Jedco International Pharmaceutical

JC Biological Technology

Catalent

CapsCanada

Bahrain Pharma

Arab-Caps

Aenova

ACPL

ACG Associated Capsules

Non-animal Type Hard Capsules Segment by Type

Type I

00E

0E

Non-animal Type Hard Capsules Segment by Application

Pharmaceutical

Nutraceutical

Cosmetics

Non-animal Type Hard Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-animal Type Hard Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-animal Type Hard Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-animal Type Hard Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Non-animal Type Hard Capsules in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Non-animal Type Hard Capsules manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-animal Type Hard Capsules sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Non-animal Type Hard Capsules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Type I Major Manufacturers Table 3. 00E Major Manufacturers Table 4. 0E Major Manufacturers Table 5. Global Non-animal Type Hard Capsules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Pharmaceutical Major Manufacturers Table 7. Nutraceutical Major Manufacturers Table 8. Cosmetics Major Manufacturers Table 9. Non-animal Type Hard Capsules Industry Trends Table 10. Non-animal Type Hard Capsules Industry Drivers Table 11. Non-animal Type Hard Capsules Industry Opportunities and Challenges Table 12. Non-animal Type Hard Capsules Industry Restraints Table 13. Global Non-animal Type Hard Capsules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Non-animal Type Hard Capsules Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Non-animal Type Hard Capsules Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Non-animal Type Hard Capsules Revenue Market Share by Region (2021-2026) Table 17. Global Non-animal Type Hard Capsules Revenue Market Share by Region (2027-2032) Table 18. Global Non-animal Type Hard Capsules Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Non-animal Type Hard Capsules Sales by Region (2021-2026) & (k units) Table 20. Global Non-animal Type Hard Capsules Sales by Region (2027-2032) & (k units) Table 21. Global Non-animal Type Hard Capsules Sales Market Share by Region (2021-2026) Table 22. Global Non-animal Type Hard Capsules Sales Market Share by Region (2027-2032) Table 23. Global Non-animal Type Hard Capsules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Non-animal Type Hard Capsules Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Non-animal Type Hard Capsules Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Non-animal Type Hard Capsules Sales Market Share by Manufacturers (2021-2026) Table 27. Global Non-animal Type Hard Capsules Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global Non-animal Type Hard Capsules Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Non-animal Type Hard Capsules Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Non-animal Type Hard Capsules Manufacturers, Product Type & Application Table 31. Global Non-animal Type Hard Capsules Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Non-animal Type Hard Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Non-animal Type Hard Capsules Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Non-animal Type Hard Capsules Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Non-animal Type Hard Capsules Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Non-animal Type Hard Capsules Revenue Market Share by Type (2021-2026) Table 38. Global Non-animal Type Hard Capsules Revenue Market Share by Type (2027-2032) Table 39. Global Non-animal Type Hard Capsules Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Non-animal Type Hard Capsules Sales by Type (2021-2026) & (k units) Table 41. Global Non-animal Type Hard Capsules Sales by Type (2027-2032) & (k units) Table 42. Global Non-animal Type Hard Capsules Sales Market Share by Type (2021-2026) Table 43. Global Non-animal Type Hard Capsules Sales Market Share by Type (2027-2032) Table 44. Global Non-animal Type Hard Capsules Price by Type (2021-2026) & (US$/unit) Table 45. Global Non-animal Type Hard Capsules Price by Type (2027-2032) & (US$/unit) Table 46. Global Non-animal Type Hard Capsules Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Non-animal Type Hard Capsules Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Non-animal Type Hard Capsules Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Non-animal Type Hard Capsules Revenue Market Share by Application (2021-2026) Table 50. Global Non-animal Type Hard Capsules Revenue Market Share by Application (2027-2032) Table 51. Global Non-animal Type Hard Capsules Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Non-animal Type Hard Capsules Sales by Application (2021-2026) & (k units) Table 53. Global Non-animal Type Hard Capsules Sales by Application (2027-2032) & (k units) Table 54. Global Non-animal Type Hard Capsules Sales Market Share by Application (2021-2026) Table 55. Global Non-animal Type Hard Capsules Sales Market Share by Application (2027-2032) Table 56. Global Non-animal Type Hard Capsules Price by Application (2021-2026) & (US$/unit) Table 57. Global Non-animal Type Hard Capsules Price by Application (2027-2032) & (US$/unit) Table 58. Lonza Company Information Table 59. Lonza Business Overview Table 60. Lonza Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Lonza Non-animal Type Hard Capsules Product Portfolio Table 62. Lonza Recent Development Table 63. Hunan Er-Kang Pharmaceutical Co., Ltd Company Information Table 64. Hunan Er-Kang Pharmaceutical Co., Ltd Business Overview Table 65. Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Product Portfolio Table 67. Hunan Er-Kang Pharmaceutical Co., Ltd Recent Development Table 68. Sunil Healthcare Company Information Table 69. Sunil Healthcare Business Overview Table 70. Sunil Healthcare Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Sunil Healthcare Non-animal Type Hard Capsules Product Portfolio Table 72. Sunil Healthcare Recent Development Table 73. Roxlor Company Information Table 74. Roxlor Business Overview Table 75. Roxlor Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Roxlor Non-animal Type Hard Capsules Product Portfolio Table 77. Roxlor Recent Development Table 78. Qualicaps (Mitsubishi Chemical) Company Information Table 79. Qualicaps (Mitsubishi Chemical) Business Overview Table 80. Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Product Portfolio Table 82. Qualicaps (Mitsubishi Chemical) Recent Development Table 83. Procaps S.A Company Information Table 84. Procaps S.A Business Overview Table 85. Procaps S.A Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Procaps S.A Non-animal Type Hard Capsules Product Portfolio Table 87. Procaps S.A Recent Development Table 88. Pharco Company Information Table 89. Pharco Business Overview Table 90. Pharco Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Pharco Non-animal Type Hard Capsules Product Portfolio Table 92. Pharco Recent Development Table 93. Patheon (Banner Pharmacaps) Company Information Table 94. Patheon (Banner Pharmacaps) Business Overview Table 95. Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Product Portfolio Table 97. Patheon (Banner Pharmacaps) Recent Development Table 98. Medicaps Company Information Table 99. Medicaps Business Overview Table 100. Medicaps Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Medicaps Non-animal Type Hard Capsules Product Portfolio Table 102. Medicaps Recent Development Table 103. Jedco International Pharmaceutical Company Information Table 104. Jedco International Pharmaceutical Business Overview Table 105. Jedco International Pharmaceutical Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Jedco International Pharmaceutical Non-animal Type Hard Capsules Product Portfolio Table 107. Jedco International Pharmaceutical Recent Development Table 108. JC Biological Technology Company Information Table 109. JC Biological Technology Business Overview Table 110. JC Biological Technology Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. JC Biological Technology Non-animal Type Hard Capsules Product Portfolio Table 112. JC Biological Technology Recent Development Table 113. Catalent Company Information Table 114. Catalent Business Overview Table 115. Catalent Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Catalent Non-animal Type Hard Capsules Product Portfolio Table 117. Catalent Recent Development Table 118. CapsCanada Company Information Table 119. CapsCanada Business Overview Table 120. CapsCanada Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. CapsCanada Non-animal Type Hard Capsules Product Portfolio Table 122. CapsCanada Recent Development Table 123. Bahrain Pharma Company Information Table 124. Bahrain Pharma Business Overview Table 125. Bahrain Pharma Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Bahrain Pharma Non-animal Type Hard Capsules Product Portfolio Table 127. Bahrain Pharma Recent Development Table 128. Arab-Caps Company Information Table 129. Arab-Caps Business Overview Table 130. Arab-Caps Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. Arab-Caps Non-animal Type Hard Capsules Product Portfolio Table 132. Arab-Caps Recent Development Table 133. Aenova Company Information Table 134. Aenova Business Overview Table 135. Aenova Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 136. Aenova Non-animal Type Hard Capsules Product Portfolio Table 137. Aenova Recent Development Table 138. ACPL Company Information Table 139. ACPL Business Overview Table 140. ACPL Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 141. ACPL Non-animal Type Hard Capsules Product Portfolio Table 142. ACPL Recent Development Table 143. ACG Associated Capsules Company Information Table 144. ACG Associated Capsules Business Overview Table 145. ACG Associated Capsules Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 146. ACG Associated Capsules Non-animal Type Hard Capsules Product Portfolio Table 147. ACG Associated Capsules Recent Development Table 148. North America Non-animal Type Hard Capsules Revenue by Type (2021-2026) & (US$ Million) Table 149. North America Non-animal Type Hard Capsules Revenue by Type (2027-2032) & (US$ Million) Table 150. North America Non-animal Type Hard Capsules Sales by Type (2021-2026) & (k units) Table 151. North America Non-animal Type Hard Capsules Sales by Type (2027-2032) & (k units) Table 152. North America Non-animal Type Hard Capsules Sales Price by Type (2021-2026) & (US$/unit) Table 153. North America Non-animal Type Hard Capsules Sales Price by Type (2027-2032) & (US$/unit) Table 154. North America Non-animal Type Hard Capsules Revenue by Application (2021-2026) & (US$ Million) Table 155. North America Non-animal Type Hard Capsules Revenue by Application (2027-2032) & (US$ Million) Table 156. North America Non-animal Type Hard Capsules Sales by Application (2021-2026) & (k units) Table 157. North America Non-animal Type Hard Capsules Sales by Application (2027-2032) & (k units) Table 158. North America Non-animal Type Hard Capsules Sales Price by Application (2021-2026) & (US$/unit) Table 159. North America Non-animal Type Hard Capsules Sales Price by Application (2027-2032) & (US$/unit) Table 160. North America Non-animal Type Hard Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. North America Non-animal Type Hard Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 162. North America Non-animal Type Hard Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 163. North America Non-animal Type Hard Capsules Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 164. North America Non-animal Type Hard Capsules Sales by Country (2021-2026) & (k units) Table 165. North America Non-animal Type Hard Capsules Sales by Country (2027-2032) & (k units) Table 166. North America Non-animal Type Hard Capsules Sales Price by Country (2021-2026) & (US$/unit) Table 167. North America Non-animal Type Hard Capsules Sales Price by Country (2027-2032) & (US$/unit) Table 168. United States Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 169. Canada Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 170. Mexico Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 171. Europe Non-animal Type Hard Capsules Revenue by Type (2021-2026) & (US$ Million) Table 172. Europe Non-animal Type Hard Capsules Revenue by Type (2027-2032) & (US$ Million) Table 173. Europe Non-animal Type Hard Capsules Sales by Type (2021-2026) & (k units) Table 174. Europe Non-animal Type Hard Capsules Sales by Type (2027-2032) & (k units) Table 175. Europe Non-animal Type Hard Capsules Sales Price by Type (2021-2026) & (US$/unit) Table 176. Europe Non-animal Type Hard Capsules Sales Price by Type (2027-2032) & (US$/unit) Table 177. Europe Non-animal Type Hard Capsules Revenue by Application (2021-2026) & (US$ Million) Table 178. Europe Non-animal Type Hard Capsules Revenue by Application (2027-2032) & (US$ Million) Table 179. Europe Non-animal Type Hard Capsules Sales by Application (2021-2026) & (k units) Table 180. Europe Non-animal Type Hard Capsules Sales by Application (2027-2032) & (k units) Table 181. Europe Non-animal Type Hard Capsules Sales Price by Application (2021-2026) & (US$/unit) Table 182. Europe Non-animal Type Hard Capsules Sales Price by Application (2027-2032) & (US$/unit) Table 183. Europe Non-animal Type Hard Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 184. Europe Non-animal Type Hard Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 185. Europe Non-animal Type Hard Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 186. Europe Non-animal Type Hard Capsules Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 187. Europe Non-animal Type Hard Capsules Sales by Country (2021-2026) & (k units) Table 188. Europe Non-animal Type Hard Capsules Sales by Country (2027-2032) & (k units) Table 189. Europe Non-animal Type Hard Capsules Sales Price by Country (2021-2026) & (US$/unit) Table 190. Europe Non-animal Type Hard Capsules Sales Price by Country (2027-2032) & (US$/unit) Table 191. Germany Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 192. France Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 193. U.K. Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 194. Italy Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 195. Russia Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 196. Spain Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 197. Netherlands Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 198. Switzerland Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 199. Sweden Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 200. Poland Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 201. China Non-animal Type Hard Capsules Revenue by Type (2021-2026) & (US$ Million) Table 202. China Non-animal Type Hard Capsules Revenue by Type (2027-2032) & (US$ Million) Table 203. China Non-animal Type Hard Capsules Sales by Type (2021-2026) & (k units) Table 204. China Non-animal Type Hard Capsules Sales by Type (2027-2032) & (k units) Table 205. China Non-animal Type Hard Capsules Sales Price by Type (2021-2026) & (US$/unit) Table 206. China Non-animal Type Hard Capsules Sales Price by Type (2027-2032) & (US$/unit) Table 207. China Non-animal Type Hard Capsules Revenue by Application (2021-2026) & (US$ Million) Table 208. China Non-animal Type Hard Capsules Revenue by Application (2027-2032) & (US$ Million) Table 209. China Non-animal Type Hard Capsules Sales by Application (2021-2026) & (k units) Table 210. China Non-animal Type Hard Capsules Sales by Application (2027-2032) & (k units) Table 211. China Non-animal Type Hard Capsules Sales Price by Application (2021-2026) & (US$/unit) Table 212. China Non-animal Type Hard Capsules Sales Price by Application (2027-2032) & (US$/unit) Table 213. Asia Non-animal Type Hard Capsules Revenue by Type (2021-2026) & (US$ Million) Table 214. Asia Non-animal Type Hard Capsules Revenue by Type (2027-2032) & (US$ Million) Table 215. Asia Non-animal Type Hard Capsules Sales by Type (2021-2026) & (k units) Table 216. Asia Non-animal Type Hard Capsules Sales by Type (2027-2032) & (k units) Table 217. Asia Non-animal Type Hard Capsules Sales Price by Type (2021-2026) & (US$/unit) Table 218. Asia Non-animal Type Hard Capsules Sales Price by Type (2027-2032) & (US$/unit) Table 219. Asia Non-animal Type Hard Capsules Revenue by Application (2021-2026) & (US$ Million) Table 220. Asia Non-animal Type Hard Capsules Revenue by Application (2027-2032) & (US$ Million) Table 221. Asia Non-animal Type Hard Capsules Sales by Application (2021-2026) & (k units) Table 222. Asia Non-animal Type Hard Capsules Sales by Application (2027-2032) & (k units) Table 223. Asia Non-animal Type Hard Capsules Sales Price by Application (2021-2026) & (US$/unit) Table 224. Asia Non-animal Type Hard Capsules Sales Price by Application (2027-2032) & (US$/unit) Table 225. Asia Non-animal Type Hard Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 226. Asia Non-animal Type Hard Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 227. Asia Non-animal Type Hard Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 228. Asia Non-animal Type Hard Capsules Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 229. Asia Non-animal Type Hard Capsules Sales by Country (2021-2026) & (k units) Table 230. Asia Non-animal Type Hard Capsules Sales by Country (2027-2032) & (k units) Table 231. Asia Non-animal Type Hard Capsules Sales Price by Country (2021-2026) & (US$/unit) Table 232. Asia Non-animal Type Hard Capsules Sales Price by Country (2027-2032) & (US$/unit) Table 233. Japan Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 234. South Korea Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 235. India Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 236. Australia Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 237. Taiwan Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 238. Southeast Asia Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 239. SAMEA Non-animal Type Hard Capsules Revenue by Type (2021-2026) & (US$ Million) Table 240. SAMEA Non-animal Type Hard Capsules Revenue by Type (2027-2032) & (US$ Million) Table 241. SAMEA Non-animal Type Hard Capsules Sales by Type (2021-2026) & (k units) Table 242. SAMEA Non-animal Type Hard Capsules Sales by Type (2027-2032) & (k units) Table 243. SAMEA Non-animal Type Hard Capsules Sales Price by Type (2021-2026) & (US$/unit) Table 244. SAMEA Non-animal Type Hard Capsules Sales Price by Type (2027-2032) & (US$/unit) Table 245. SAMEA Non-animal Type Hard Capsules Revenue by Application (2021-2026) & (US$ Million) Table 246. SAMEA Non-animal Type Hard Capsules Revenue by Application (2027-2032) & (US$ Million) Table 247. SAMEA Non-animal Type Hard Capsules Sales by Application (2021-2026) & (k units) Table 248. SAMEA Non-animal Type Hard Capsules Sales by Application (2027-2032) & (k units) Table 249. SAMEA Non-animal Type Hard Capsules Sales Price by Application (2021-2026) & (US$/unit) Table 250. SAMEA Non-animal Type Hard Capsules Sales Price by Application (2027-2032) & (US$/unit) Table 251. SAMEA Non-animal Type Hard Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 252. SAMEA Non-animal Type Hard Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 253. SAMEA Non-animal Type Hard Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 254. SAMEA Non-animal Type Hard Capsules Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 255. SAMEA Non-animal Type Hard Capsules Sales by Country (2021-2026) & (k units) Table 256. SAMEA Non-animal Type Hard Capsules Sales by Country (2027-2032) & (k units) Table 257. SAMEA Non-animal Type Hard Capsules Sales Price by Country (2021-2026) & (US$/unit) Table 258. SAMEA Non-animal Type Hard Capsules Sales Price by Country (2027-2032) & (US$/unit) Table 259. Brazil Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 260. Argentina Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 261. Chile Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 262. Colombia Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 263. Peru Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 264. Saudi Arabia Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 265. Israel Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 266. UAE Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 267. Turkey Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 268. Iran Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 269. Egypt Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Table 270. Key Raw Materials Table 271. Raw Materials Key Suppliers Table 272. Non-animal Type Hard Capsules Distributors List Table 273. Non-animal Type Hard Capsules Customers List Table 274. Research Programs/Design for This Report Table 275. Authors List of This Report Table 276. Secondary Sources Table 277. Primary Sources List of Figures Figure 1. Non-animal Type Hard Capsules Image Figure 2. Global Non-animal Type Hard Capsules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-animal Type Hard Capsules Market Size Share 2021 VS 2025 VS 2032 Figure 4. Type I Image Figure 5. 00E Image Figure 6. 0E Image Figure 7. Global Non-animal Type Hard Capsules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Non-animal Type Hard Capsules Market Size Share 2021 VS 2025 VS 2032 Figure 9. Pharmaceutical Image Figure 10. Nutraceutical Image Figure 11. Cosmetics Image Figure 12. Global Non-animal Type Hard Capsules Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Non-animal Type Hard Capsules Revenue (2021-2032) & (US$ Million) Figure 14. Global Non-animal Type Hard Capsules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Non-animal Type Hard Capsules Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Non-animal Type Hard Capsules Revenue Market Share by Region (2021-2032) Figure 17. Global Non-animal Type Hard Capsules Sales (2021-2032) & (k units) Figure 18. Global Non-animal Type Hard Capsules Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Non-animal Type Hard Capsules Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Non-animal Type Hard Capsules Sales YoY (2021-2032) & (k units) Figure 21. Europe Non-animal Type Hard Capsules Sales YoY (2021-2032) & (k units) Figure 22. China Non-animal Type Hard Capsules Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Non-animal Type Hard Capsules Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Non-animal Type Hard Capsules Sales YoY (2021-2032) & (k units) Figure 25. Global Non-animal Type Hard Capsules Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Non-animal Type Hard Capsules Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Non-animal Type Hard Capsules Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Non-animal Type Hard Capsules Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Non-animal Type Hard Capsules Revenue Market Share by Type (2021-2032) Figure 31. Global Non-animal Type Hard Capsules Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Non-animal Type Hard Capsules Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Non-animal Type Hard Capsules Sales Market Share by Type (2021-2032) Figure 34. Global Non-animal Type Hard Capsules Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Non-animal Type Hard Capsules Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Non-animal Type Hard Capsules Revenue Market Share by Application (2021-2032) Figure 37. Global Non-animal Type Hard Capsules Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Non-animal Type Hard Capsules Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Non-animal Type Hard Capsules Sales Market Share by Application (2021-2032) Figure 40. North America Non-animal Type Hard Capsules Revenue Share by Type (2021-2032) Figure 41. North America Non-animal Type Hard Capsules Sales Share by Type (2021-2032) Figure 42. North America Non-animal Type Hard Capsules Revenue Share by Application (2021-2032) Figure 43. North America Non-animal Type Hard Capsules Sales Share by Application (2021-2032) Figure 44. North America Non-animal Type Hard Capsules Revenue Share by Country (2021-2032) Figure 45. North America Non-animal Type Hard Capsules Sales Share by Country (2021-2032) Figure 46. Europe Non-animal Type Hard Capsules Revenue Share by Type (2021-2032) Figure 47. Europe Non-animal Type Hard Capsules Sales Share by Type (2021-2032) Figure 48. Europe Non-animal Type Hard Capsules Revenue Share by Application (2021-2032) Figure 49. Europe Non-animal Type Hard Capsules Sales Share by Application (2021-2032) Figure 50. Europe Non-animal Type Hard Capsules Revenue Share by Country (2021-2032) Figure 51. Europe Non-animal Type Hard Capsules Sales Share by Country (2021-2032) Figure 52. China Non-animal Type Hard Capsules Revenue Share by Type (2021-2032) Figure 53. China Non-animal Type Hard Capsules Sales Share by Type (2021-2032) Figure 54. China Non-animal Type Hard Capsules Revenue Share by Application (2021-2032) Figure 55. China Non-animal Type Hard Capsules Sales Share by Application (2021-2032) Figure 56. Asia Non-animal Type Hard Capsules Revenue Share by Type (2021-2032) Figure 57. Asia Non-animal Type Hard Capsules Sales Share by Type (2021-2032) Figure 58. Asia Non-animal Type Hard Capsules Revenue Share by Application (2021-2032) Figure 59. Asia Non-animal Type Hard Capsules Sales Share by Application (2021-2032) Figure 60. Asia Non-animal Type Hard Capsules Revenue Share by Country (2021-2032) Figure 61. Asia Non-animal Type Hard Capsules Sales Share by Country (2021-2032) Figure 62. SAMEA Non-animal Type Hard Capsules Revenue Share by Type (2021-2032) Figure 63. SAMEA Non-animal Type Hard Capsules Sales Share by Type (2021-2032) Figure 64. SAMEA Non-animal Type Hard Capsules Revenue Share by Application (2021-2032) Figure 65. SAMEA Non-animal Type Hard Capsules Sales Share by Application (2021-2032) Figure 66. SAMEA Non-animal Type Hard Capsules Revenue Share by Country (2021-2032) Figure 67. SAMEA Non-animal Type Hard Capsules Sales Share by Country (2021-2032) Figure 68. Non-animal Type Hard Capsules Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Non-animal Type Hard Capsules Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Type I
  • 00E
  • 0E
Applications
  • Pharmaceutical
  • Nutraceutical
  • Cosmetics
Companies covered
  • Lonza
  • Hunan Er-Kang Pharmaceutical Co., Ltd
  • Sunil Healthcare
  • Roxlor
  • Qualicaps (Mitsubishi Chemical)
  • Procaps S.A
  • Pharco
  • Patheon (Banner Pharmacaps)
  • Medicaps
  • Jedco International Pharmaceutical
  • JC Biological Technology
  • Catalent
  • CapsCanada
  • Bahrain Pharma
  • Arab-Caps
  • Aenova
  • ACPL
  • ACG Associated Capsules

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Non-animal Type Hard Capsules Market by Type
  3. 1.2.1 Global Non-animal Type Hard Capsules Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Type I
  5. 1.2.3 00E
  6. 1.2.4 0E
  7. 1.3 Non-animal Type Hard Capsules Market by Application
  8. 1.3.1 Global Non-animal Type Hard Capsules Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Pharmaceutical
  10. 1.3.3 Nutraceutical
  11. 1.3.4 Cosmetics
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Non-animal Type Hard Capsules Market Dynamics
  1. 2.1 Non-animal Type Hard Capsules Industry Trends
  2. 2.2 Non-animal Type Hard Capsules Industry Drivers
  3. 2.3 Non-animal Type Hard Capsules Industry Opportunities and Challenges
  4. 2.4 Non-animal Type Hard Capsules Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Non-animal Type Hard Capsules Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Non-animal Type Hard Capsules Revenue by Region
  3. 3.2.1 Global Non-animal Type Hard Capsules Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Non-animal Type Hard Capsules Revenue by Region (2021-2026)
  5. 3.2.3 Global Non-animal Type Hard Capsules Revenue by Region (2027-2032)
  6. 3.2.4 Global Non-animal Type Hard Capsules Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Non-animal Type Hard Capsules Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Non-animal Type Hard Capsules Sales by Region
  9. 3.4.1 Global Non-animal Type Hard Capsules Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Non-animal Type Hard Capsules Sales by Region (2021-2026)
  11. 3.4.3 Global Non-animal Type Hard Capsules Sales by Region (2027-2032)
  12. 3.4.4 Global Non-animal Type Hard Capsules Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Non-animal Type Hard Capsules Revenue by Manufacturers
  2. 4.1.1 Global Non-animal Type Hard Capsules Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Non-animal Type Hard Capsules Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Non-animal Type Hard Capsules Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Non-animal Type Hard Capsules Sales by Manufacturers
  6. 4.2.1 Global Non-animal Type Hard Capsules Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Non-animal Type Hard Capsules Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Non-animal Type Hard Capsules Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Non-animal Type Hard Capsules Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Non-animal Type Hard Capsules Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Non-animal Type Hard Capsules Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Non-animal Type Hard Capsules Manufacturers, Product Type & Application
  13. 4.7 Global Non-animal Type Hard Capsules Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Non-animal Type Hard Capsules Market CR5 and HHI
  16. 4.8.2 2025 Non-animal Type Hard Capsules Tier 1, Tier 2, and Tier 3
5 Non-animal Type Hard Capsules Market by Type
  1. 5.1 Global Non-animal Type Hard Capsules Revenue by Type
  2. 5.1.1 Global Non-animal Type Hard Capsules Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Non-animal Type Hard Capsules Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Non-animal Type Hard Capsules Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Non-animal Type Hard Capsules Sales by Type
  6. 5.2.1 Global Non-animal Type Hard Capsules Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Non-animal Type Hard Capsules Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Non-animal Type Hard Capsules Sales Market Share by Type (2021-2032)
  9. 5.3 Global Non-animal Type Hard Capsules Price by Type
6 Non-animal Type Hard Capsules Market by Application
  1. 6.1 Global Non-animal Type Hard Capsules Revenue by Application
  2. 6.1.1 Global Non-animal Type Hard Capsules Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Non-animal Type Hard Capsules Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Non-animal Type Hard Capsules Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Non-animal Type Hard Capsules Sales by Application
  6. 6.2.1 Global Non-animal Type Hard Capsules Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Non-animal Type Hard Capsules Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Non-animal Type Hard Capsules Sales Market Share by Application (2021-2032)
  9. 6.3 Global Non-animal Type Hard Capsules Price by Application
7 Company Profiles
  1. 7.1 Lonza
  2. 7.1.1 Lonza Company Information
  3. 7.1.2 Lonza Business Overview
  4. 7.1.3 Lonza Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Lonza Non-animal Type Hard Capsules Product Portfolio
  6. 7.1.5 Lonza Recent Developments
  7. 7.2 Hunan Er-Kang Pharmaceutical Co., Ltd
  8. 7.2.1 Hunan Er-Kang Pharmaceutical Co., Ltd Company Information
  9. 7.2.2 Hunan Er-Kang Pharmaceutical Co., Ltd Business Overview
  10. 7.2.3 Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Product Portfolio
  12. 7.2.5 Hunan Er-Kang Pharmaceutical Co., Ltd Recent Developments
  13. 7.3 Sunil Healthcare
  14. 7.3.1 Sunil Healthcare Company Information
  15. 7.3.2 Sunil Healthcare Business Overview
  16. 7.3.3 Sunil Healthcare Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sunil Healthcare Non-animal Type Hard Capsules Product Portfolio
  18. 7.3.5 Sunil Healthcare Recent Developments
  19. 7.4 Roxlor
  20. 7.4.1 Roxlor Company Information
  21. 7.4.2 Roxlor Business Overview
  22. 7.4.3 Roxlor Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Roxlor Non-animal Type Hard Capsules Product Portfolio
  24. 7.4.5 Roxlor Recent Developments
  25. 7.5 Qualicaps (Mitsubishi Chemical)
  26. 7.5.1 Qualicaps (Mitsubishi Chemical) Company Information
  27. 7.5.2 Qualicaps (Mitsubishi Chemical) Business Overview
  28. 7.5.3 Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Product Portfolio
  30. 7.5.5 Qualicaps (Mitsubishi Chemical) Recent Developments
  31. 7.6 Procaps S.A
  32. 7.6.1 Procaps S.A Company Information
  33. 7.6.2 Procaps S.A Business Overview
  34. 7.6.3 Procaps S.A Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Procaps S.A Non-animal Type Hard Capsules Product Portfolio
  36. 7.6.5 Procaps S.A Recent Developments
  37. 7.7 Pharco
  38. 7.7.1 Pharco Company Information
  39. 7.7.2 Pharco Business Overview
  40. 7.7.3 Pharco Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pharco Non-animal Type Hard Capsules Product Portfolio
  42. 7.7.5 Pharco Recent Developments
  43. 7.8 Patheon (Banner Pharmacaps)
  44. 7.8.1 Patheon (Banner Pharmacaps) Company Information
  45. 7.8.2 Patheon (Banner Pharmacaps) Business Overview
  46. 7.8.3 Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Product Portfolio
  48. 7.8.5 Patheon (Banner Pharmacaps) Recent Developments
  49. 7.9 Medicaps
  50. 7.9.1 Medicaps Company Information
  51. 7.9.2 Medicaps Business Overview
  52. 7.9.3 Medicaps Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Medicaps Non-animal Type Hard Capsules Product Portfolio
  54. 7.9.5 Medicaps Recent Developments
  55. 7.10 Jedco International Pharmaceutical
  56. 7.10.1 Jedco International Pharmaceutical Company Information
  57. 7.10.2 Jedco International Pharmaceutical Business Overview
  58. 7.10.3 Jedco International Pharmaceutical Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Jedco International Pharmaceutical Non-animal Type Hard Capsules Product Portfolio
  60. 7.10.5 Jedco International Pharmaceutical Recent Developments
  61. 7.11 JC Biological Technology
  62. 7.11.1 JC Biological Technology Company Information
  63. 7.11.2 JC Biological Technology Business Overview
  64. 7.11.3 JC Biological Technology Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 JC Biological Technology Non-animal Type Hard Capsules Product Portfolio
  66. 7.11.5 JC Biological Technology Recent Developments
  67. 7.12 Catalent
  68. 7.12.1 Catalent Company Information
  69. 7.12.2 Catalent Business Overview
  70. 7.12.3 Catalent Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Catalent Non-animal Type Hard Capsules Product Portfolio
  72. 7.12.5 Catalent Recent Developments
  73. 7.13 CapsCanada
  74. 7.13.1 CapsCanada Company Information
  75. 7.13.2 CapsCanada Business Overview
  76. 7.13.3 CapsCanada Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 CapsCanada Non-animal Type Hard Capsules Product Portfolio
  78. 7.13.5 CapsCanada Recent Developments
  79. 7.14 Bahrain Pharma
  80. 7.14.1 Bahrain Pharma Company Information
  81. 7.14.2 Bahrain Pharma Business Overview
  82. 7.14.3 Bahrain Pharma Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Bahrain Pharma Non-animal Type Hard Capsules Product Portfolio
  84. 7.14.5 Bahrain Pharma Recent Developments
  85. 7.15 Arab-Caps
  86. 7.15.1 Arab-Caps Company Information
  87. 7.15.2 Arab-Caps Business Overview
  88. 7.15.3 Arab-Caps Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Arab-Caps Non-animal Type Hard Capsules Product Portfolio
  90. 7.15.5 Arab-Caps Recent Developments
  91. 7.16 Aenova
  92. 7.16.1 Aenova Company Information
  93. 7.16.2 Aenova Business Overview
  94. 7.16.3 Aenova Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Aenova Non-animal Type Hard Capsules Product Portfolio
  96. 7.16.5 Aenova Recent Developments
  97. 7.17 ACPL
  98. 7.17.1 ACPL Company Information
  99. 7.17.2 ACPL Business Overview
  100. 7.17.3 ACPL Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 ACPL Non-animal Type Hard Capsules Product Portfolio
  102. 7.17.5 ACPL Recent Developments
  103. 7.18 ACG Associated Capsules
  104. 7.18.1 ACG Associated Capsules Company Information
  105. 7.18.2 ACG Associated Capsules Business Overview
  106. 7.18.3 ACG Associated Capsules Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 ACG Associated Capsules Non-animal Type Hard Capsules Product Portfolio
  108. 7.18.5 ACG Associated Capsules Recent Developments
8 North America
  1. 8.1 North America Non-animal Type Hard Capsules Market Size by Type
  2. 8.1.1 North America Non-animal Type Hard Capsules Revenue by Type (2021-2032)
  3. 8.1.2 North America Non-animal Type Hard Capsules Sales by Type (2021-2032)
  4. 8.1.3 North America Non-animal Type Hard Capsules Price by Type (2021-2032)
  5. 8.2 North America Non-animal Type Hard Capsules Market Size by Application
  6. 8.2.1 North America Non-animal Type Hard Capsules Revenue by Application (2021-2032)
  7. 8.2.2 North America Non-animal Type Hard Capsules Sales by Application (2021-2032)
  8. 8.2.3 North America Non-animal Type Hard Capsules Price by Application (2021-2032)
  9. 8.3 North America Non-animal Type Hard Capsules Market Size by Country
  10. 8.3.1 North America Non-animal Type Hard Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Non-animal Type Hard Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Non-animal Type Hard Capsules Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Non-animal Type Hard Capsules Market Size by Type
  2. 9.1.1 Europe Non-animal Type Hard Capsules Revenue by Type (2021-2032)
  3. 9.1.2 Europe Non-animal Type Hard Capsules Sales by Type (2021-2032)
  4. 9.1.3 Europe Non-animal Type Hard Capsules Price by Type (2021-2032)
  5. 9.2 Europe Non-animal Type Hard Capsules Market Size by Application
  6. 9.2.1 Europe Non-animal Type Hard Capsules Revenue by Application (2021-2032)
  7. 9.2.2 Europe Non-animal Type Hard Capsules Sales by Application (2021-2032)
  8. 9.2.3 Europe Non-animal Type Hard Capsules Price by Application (2021-2032)
  9. 9.3 Europe Non-animal Type Hard Capsules Market Size by Country
  10. 9.3.1 Europe Non-animal Type Hard Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Non-animal Type Hard Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Non-animal Type Hard Capsules Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Non-animal Type Hard Capsules Market Size by Type
  2. 10.1.1 China Non-animal Type Hard Capsules Revenue by Type (2021-2032)
  3. 10.1.2 China Non-animal Type Hard Capsules Sales by Type (2021-2032)
  4. 10.1.3 China Non-animal Type Hard Capsules Price by Type (2021-2032)
  5. 10.2 China Non-animal Type Hard Capsules Market Size by Application
  6. 10.2.1 China Non-animal Type Hard Capsules Revenue by Application (2021-2032)
  7. 10.2.2 China Non-animal Type Hard Capsules Sales by Application (2021-2032)
  8. 10.2.3 China Non-animal Type Hard Capsules Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Non-animal Type Hard Capsules Market Size by Type
  2. 11.1.1 Asia Non-animal Type Hard Capsules Revenue by Type (2021-2032)
  3. 11.1.2 Asia Non-animal Type Hard Capsules Sales by Type (2021-2032)
  4. 11.1.3 Asia Non-animal Type Hard Capsules Price by Type (2021-2032)
  5. 11.2 Asia Non-animal Type Hard Capsules Market Size by Application
  6. 11.2.1 Asia Non-animal Type Hard Capsules Revenue by Application (2021-2032)
  7. 11.2.2 Asia Non-animal Type Hard Capsules Sales by Application (2021-2032)
  8. 11.2.3 Asia Non-animal Type Hard Capsules Price by Application (2021-2032)
  9. 11.3 Asia Non-animal Type Hard Capsules Market Size by Country
  10. 11.3.1 Asia Non-animal Type Hard Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Non-animal Type Hard Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Non-animal Type Hard Capsules Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Non-animal Type Hard Capsules Market Size by Type
  2. 12.1.1 SAMEA Non-animal Type Hard Capsules Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Non-animal Type Hard Capsules Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Non-animal Type Hard Capsules Price by Type (2021-2032)
  5. 12.2 SAMEA Non-animal Type Hard Capsules Market Size by Application
  6. 12.2.1 SAMEA Non-animal Type Hard Capsules Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Non-animal Type Hard Capsules Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Non-animal Type Hard Capsules Price by Application (2021-2032)
  9. 12.3 SAMEA Non-animal Type Hard Capsules Market Size by Country
  10. 12.3.1 SAMEA Non-animal Type Hard Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Non-animal Type Hard Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Non-animal Type Hard Capsules Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Non-animal Type Hard Capsules Value Chain Analysis
  2. 13.1.1 Non-animal Type Hard Capsules Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Non-animal Type Hard Capsules Production Mode & Process
  6. 13.2 Non-animal Type Hard Capsules Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Non-animal Type Hard Capsules Distributors
  9. 13.2.3 Non-animal Type Hard Capsules Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst